Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide is designed as a once-weekly injectable triple hormone receptor agonist that activates the receptors for:
GLP-1 (glucagon-like peptide-1)
GIP (glucose-dependent insulinotropic polypeptide)
Glucagon
This triple-receptor action aims to improve appetite regulation, glucose control, and energy expenditure — potentially leading to greater metabolic effects than earlier drugs targeting only one or two pathways.
Retatrutide is designed as a once-weekly injectable triple hormone receptor agonist that activates the receptors for:
GLP-1 (glucagon-like peptide-1)
GIP (glucose-dependent insulinotropic polypeptide)
Glucagon
This triple-receptor action aims to improve appetite regulation, glucose control, and energy expenditure — potentially leading to greater metabolic effects than earlier drugs targeting only one or two pathways.